JP Morgan Maintains Overweight on Helmerich & Payne, Lowers Price Target to $43

JP Morgan maintains Helmerich & Payne (NYSE:HP) with a Overweight and lowers the price target from $45 to $43.

Benzinga · 11/18/2019 15:20

JP Morgan maintains Helmerich & Payne (NYSE:HP) with a Overweight and lowers the price target from $45 to $43.